Randomized trial in Zimbabwe suggests how to make HIV testing and counselling attractive

July 03, 2006

HIV counselling and testing is a key component of both HIV care and HIV prevention, but uptake of counselling and testing is often low. Liz Corbett and colleagues investigated the impact of rapid HIV testing at the workplace on uptake of voluntary counselling and testing in Harare, Zimbabwe. Uptake was high when testing and counseling was offered on-site at the workplace and linked to basic HIV care.

These results suggest that this approach could improve uptake of HIV testing in Africa from its current low level. The results also suggest that providing counselling and testing intermittently might be as effective as continuous provision. The researchers conclude that a relatively minor change in accessibility to testing can translate into a major difference in test uptake. This may hold true in non-occupational settings as well.

All works published in PLoS Medicine are open access. Everything is immediately available without cost to anyone, anywhere--to read, download, redistribute, include in databases, and otherwise use--subject only to the condition that the original authorship is properly attributed. Copyright is retained by the authors. The Public Library of Science uses the Creative Commons Attribution License.

Citation: Corbett EL, Dauya E, Matambo R, Cheung YB, Makamure B, et al. (2006) Uptake of workplace HIV counselling and testing: A cluster-randomised trial in Zimbabwe. PLoS Med 3(7): e238.

VERSIONS OF YOUR REPORT: http://dx.doi.org/10.1371/journal.pmed.0030238

PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-03-07-corbett.pdf

Elizabeth Corbett
London School of Hygiene and Tropical Medicine
Infectious and Tropical Diseases
Keppel Street
London, WC1E 7HT
United Kingdom
263 4 744 634
263 4 303 978 (fax)

About PLoS Medicine
PLoS Medicine is an open access, freely available international medical journal. It publishes original research that enhances our understanding of human health and disease, together with commentary and analysis of important global health issues. For more information, visit http://www.plosmedicine.org


Related HIV Prevention Articles from Brightsurf:

Many practitioners are not prescribing HIV prevention medication, study finds
Only about 54% of medical practitioners surveyed say they have prescribed pre-exposure prophylaxis, or PrEP, to HIV-vulnerable patients, according to a new study by a Vanderbilt University Medical Center investigator.

State laws key to HIV prevention efforts
HIV prevention remains a public health priority in the United States.

Use of PrEP for HIV prevention among at-risk teens in US
Nearly 60 articles were reviewed to assess the rate of preexposure prophylaxis (PrEP) use for HIV prevention among at-risk teens in the United States and to provide recommendations for how to improve access to and use of PrEP.

New high-cost HIV prevention drug: 'Better' isn't worth it
A newly approved drug for HIV pre-exposure prophylaxis (PrEP) is unlikely to confer any discernible health benefit over generic alternatives and may undermine efforts to expand access to HIV prevention for the nation's most vulnerable populations, according to a new study appearing March 9 in the Annals of Internal Medicine.

Sex workers' preferences for HIV prevention center on convenience
Preventing HIV in sex workers is a powerful tool in lowering the worldwide burden of the disease, and a new study could help ensure that high-risk women take advantage of medical safeguards.

Online intervention shows promise in HIV prevention
A team led by José Bauermeister, Ph.D., M.P.H., Presidential Professor of Nursing and Director of the Program on Sexuality, Technology, & Action Research (PSTAR), at the University of Pennsylvania School of Nursing (Penn Nursing) designed the My Desires & Expectations (myDEx) tool to address cognitive and emotional factors that influence YGBMSM sexual decision-making when seeking partners online. myDEx was pilot tested in a randomized trial over 90 days with 180 YGBMSM participants.

Prevention, treatment efforts reduce HIV infection among transgender women
Programs to prevent HIV in transgender women are helping to lower the rate of new infection but better care and treatment of this vulnerable population is still needed, especially among those of lower income or people of color, according to a new Rutgers study.

Meeting the challenge of engaging men in HIV prevention and treatment
A new commentary from National Institutes of Health scientists asserts that engaging men in HIV prevention and care is essential to the goal of ending the HIV pandemic.

New guidelines for treatment and prevention of HIV infection in adults
Experts have updated recommendations for the use of antiretroviral drugs in the treatment and prevention of HIV infection.

Wider access to HIV prevention drugs still needed
Anti-HIV drugs are highly effective, yet new infections continue because not everyone has equal access to treatment.

Read More: HIV Prevention News and HIV Prevention Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.